1 completed, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Treatment Resistant: new trials by email Literature Review of Treatment Resistant trials Research Report on Treatment Resistant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Non-invasive Neuromodulation by rTMS for Chronic and Treatment Resistant Catatonia Individualized rTMS on VERUM 1's region or network, Individualized rTMS on VERUM 2's region or network, Individualized rTMS on PLACEBO region - Schizophreniform Catatonia, Treatment Resistant | Not applicable | Unknown | University Hospital, Strasbourg, France | 17 | 2017-04-24 | 2022-04-20 |
| Nuedexta in Treatment-Resistant Major Depression dextromethorphan/quinidine - Major Depressive Disorder, Treatment Resistant | Phase 2 | Completed | James Murrough | 20 | 2013-07-01 | 2018-06-11 |
Catatonia (1) · Depression (1) · Depressive Disorder, Major (1)
Behavior (2) · Behavioral Symptoms (2) · Depressive Disorder (1) · Mental Disorders (1) · Mood Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
dextromethorphan - quinidine combination (1)
James Murrough (1) · University Hospital, Strasbourg, France (1)
France (1) · United States (1)